Cargando…
1155. Coadministration of Intranasal M2SR (M2-deficient Single Replication) Investigational Influenza Vaccine with Fluzone High Dose Induces Superior Immune Responses to Fluzone High Dose Alone in 65-85 Year Old Adults
BACKGROUND: Adults over age 65 years exhibit increased susceptibility to influenza viruses, accounting for 70-85% of annual influenza-related US fatalities. Licensed vaccines mainly induce serum humoral immunity and remain the primary method of influenza prevention, but vaccine effectiveness (VE) re...
Autores principales: | Eiden, Joseph, Fierro, Carlos, White, Alexander, Davis, Matthew, Rhee, Margaret, Turner, Mark, Murray, Bryan, Herber, Renee, Aitchison, Roger, Marshall, David, Moser, Michael, Bilsel, Pamuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676864/ http://dx.doi.org/10.1093/ofid/ofad500.995 |
Ejemplares similares
-
33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults
por: Eiden, Joseph, et al.
Publicado: (2020) -
Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril
por: Witt, Jacqueline, et al.
Publicado: (2022) -
2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain
por: Eiden, Joseph, et al.
Publicado: (2019) -
Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022) -
1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults
por: Eiden, Joseph, et al.
Publicado: (2018)